MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Medpace Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 22, 2026
$619.66+1.19 (+0.19%)
Close on Oct 19, 2026
- Market cap
- $17.69B
- P/E (TTM)
- 36.3
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
88.5%
25M of 28M shares
Institutional holders
696
73 new, 100 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
0 buys · 56 sales
Net sold $436.70M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| August J. Troendle | 5,396,508 | 19.10% | 13D (active) amendment | Sep 24, 2026 |
| BlackRock, Inc. | 2,417,994 | 7.90% | 13G (passive) amendment | Dec 31, 2023 |
| T. Rowe Price Associates, Inc. | 2,069,679 | 7.20% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MEDP | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,498,248 | 8.95% | $1.32B | +27,808 | 0.02% |
| Price T Rowe Associates Inc /Md/ | 2,069,677 | 7.42% | $1.10M | +1,780,170 | 0.11% |
| Aqr Capital Management LLC | 1,278,935 | 4.58% | $677.31M | −74,902 | 0.24% |
| Vanguard Portfolio Management LLC | 1,133,357 | 4.06% | $600.21M | +11,668 | 0.03% |
| Vanguard Capital Management LLC | 1,026,820 | 3.68% | $543.79M | +15,749 | 0.01% |
| State Street Corp | 710,895 | 2.55% | $376.48M | +28,666 | 0.01% |
| Geode Capital Management, LLC | 710,465 | 2.55% | $376.31M | −34,641 | 0.02% |
| Wasatch Advisors LP | 636,595 | 2.28% | $337.13M | −137,336 | 2.21% |
| Invesco Ltd. | 579,241 | 2.08% | $306.76M | +1,667 | 0.02% |
| Baillie Gifford & Co | 473,211 | 1.70% | $250.61M | −29,980 | 0.23% |
| Arrowstreet Capital, Limited Partnership | 429,012 | 1.54% | $227.20M | +33,243 | 0.10% |
| Renaissance Technologies LLC | 415,588 | 1.49% | $220.09M | −89,080 | 0.30% |
| Dimensional Fund Advisors LP | 397,500 | 1.42% | $210.52M | +49,015 | 0.04% |
| Morgan Stanley | 317,548 | 1.14% | $168.17M | +29,126 | 0.01% |
| UBS Group AG | 303,926 | 1.09% | $160.96M | −36,507 | 0.02% |
| Bessemer Group Inc | 282,897 | 1.01% | $149.82K | −2,534 | 0.21% |
| Mawer Investment Management Ltd. | 267,175 | 0.96% | $141.49M | −178,929 | 0.96% |
| Epoch Investment Partners, Inc. | 266,547 | 0.95% | $141.16M | +125,588 | 0.80% |
| TD Asset Management Inc | 263,872 | 0.95% | $139.74M | +130,819 | 0.12% |
| Thrivent Financial for Lutherans | 256,341 | 0.92% | $135.76K | +24,849 | 0.23% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 696 | 25M | 88.5% | 73 / 205 | 307 / 100 | 4M | 3M |
| Q1 2026 | 733 | 24M | 86.4% | 87 / 237 | 300 / 134 | 5M | 3M |
| Q4 2025 | 787 | 24M | 85.5% | 180 / 262 | 259 / 53 | 3M | 3M |
| Q3 2025 | 673 | 24M | 86.6% | 139 / 183 | 272 / 61 | 2M | 5M |
| Q2 2025 | 602 | 27M | 94.9% | 76 / 224 | 227 / 54 | 4M | 3M |
| Q1 2025 | 585 | 26M | 91.5% | 68 / 234 | 212 / 69 | 3M | 2M |
| Q4 2024 | 592 | 25M | 90.9% | 100 / 216 | 210 / 82 | 3M | 3M |
| Q3 2024 | 584 | 26M | 91.7% | 72 / 245 | 198 / 106 | 5M | 3M |
| Q2 2024 | 623 | 26M | 92.1% | 76 / 238 | 235 / 43 | 3M | 3M |
| Q1 2024 | 595 | 26M | 94.1% | 95 / 185 | 247 / 40 | 3M | 2M |
| Q4 2023 | 544 | 25M | 90.2% | 96 / 201 | 182 / 34 | 3M | 2M |
| Q3 2023 | 488 | 24M | 85.9% | 74 / 154 | 186 / 45 | 3M | 3M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of MEDP | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 772,113 | 2.77% | $408.90M | 0.33% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 724,942 | 2.60% | $383.92M | 0.02% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 523,659 | 1.88% | $277.32M | 0.15% | Jun 30, 2026 |
| T. Rowe Price Large-Cap Growth Fund | 376,363 | 1.35% | $199.32M | 0.97% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 302,065 | 1.08% | $159.97M | 0.34% | Jun 30, 2026 |
| Invesco S&P MidCap Quality ETF | 295,760 | 1.06% | $170.69M | 3.13% | Jul 31, 2026 |
| Vanguard Explorer Fund | 269,615 | 0.97% | $155.60M | 0.70% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 258,774 | 0.93% | $137.04M | 0.14% | Jun 30, 2026 |
| Fullerthaler Behavioral Small Cap Equity | 173,049 | 0.62% | $91.65M | 0.72% | Jun 30, 2026 |
| iShares Biotechnology ETF | 163,042 | 0.58% | $86.35M | 0.95% | Jun 30, 2026 |
| Wasatch Core Growth Fund | 136,556 | 0.49% | $72.32M | 2.42% | Jun 30, 2026 |
| Bridge Builder Large Cap Growth Fund | 136,183 | 0.49% | $72.12M | 0.24% | Jun 30, 2026 |
| iShares Russell Mid-Cap Growth ETF | 135,882 | 0.49% | $71.96M | 0.33% | Jun 30, 2026 |
| iShares S&P Mid-Cap 400 Growth ETF | 134,962 | 0.48% | $71.47M | 0.63% | Jun 30, 2026 |
| Invesco S&P MidCap Momentum ETF | 122,494 | 0.44% | $70.69M | 0.99% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| August J. Troendle | President & CEO, Director, 10% owner | 5,119,911 | 18.34% | Sep 29, 2026 |
| Susan E. Burwig | Exec. VP, Operations | 65,984 | 0.24% | Sep 17, 2026 |
| Kevin M. Brady | CFO & Treasurer | 12,830 | 0.05% | Aug 24, 2026 |
| Brad W. Hansman | Exec. VP, Operations | 697 | 0.00% | Jun 4, 2026 |
| Stephen P. Ewald | General Counsel & Corp. Secy. | 20,343 | 0.07% | Jun 1, 2026 |
| Jesse J. Geiger | President | 46,707 | 0.17% | Mar 19, 2026 |
| Robert O. Kraft | Director | 4,813 | 0.02% | Aug 28, 2026 |
| Brian T. Carley | Director | 27,825 | 0.10% | Aug 21, 2026 |
| Fred B. Davenport Jr | Director | 11,259 | 0.04% | Aug 21, 2026 |
| Cornelius P. McCarthy III | Director | 12,275 | 0.04% | Aug 13, 2026 |
| Femida H. Gwadry-Sridhar | Director | – | – | May 18, 2026 |
| Dani S. Zander | Director | – | – | May 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| August J. Troendle President & CEO, Director, 10% owner | Sep 28, 2026 | Sale | −2,410 | $620.07 | $1.49M | 386,892 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 25, 2026 | Sale | −154 | $620.60 | $95.57K | 389,302 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 24, 2026 | Sale | −27,833 | $621.33 | $17.29M | 389,456 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 23, 2026 | Sale | −16,083 | $628.64 | $10.11M | 417,289 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 22, 2026 | Sale | −49,018 | $628.11 | $30.79M | 433,372 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 21, 2026 | Sale | −21,883 | $623.29 | $13.64M | 482,390 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 17, 2026 | Sale | −10,880 | $620.40 | $6.75M | 504,273 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 16, 2026 | Sale | −8,770 | $621.29 | $5.45M | 515,153 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 15, 2026 | Sale | −15,971 | $620.84 | $9.92M | 523,923 |
| Susan E. Burwig Exec. VP, Operations | Sep 15, 2026 | Option exercise | +3,000 | $166.73 | $500.19K | 65,984 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 27, 2026 | Sale | −650 | $620.27 | $403.18K | 539,894 |
| Robert O. Kraft Director | Aug 26, 2026 | Option exercise | +3,858 | $84.36 | $325.46K | 4,813 |
| Robert O. Kraft Director | Aug 26, 2026 | Sale | −3,858 | $617.81 | $2.38M | 955 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 26, 2026 | Sale | −4,000 | $620.03 | $2.48M | 540,544 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 25, 2026 | Sale | −673 | $620.38 | $417.52K | 544,544 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 24, 2026 | Sale | −1,983 | $620.23 | $1.23M | 545,217 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 21, 2026 | Sale | −13,995 | $624.45 | $8.74M | 547,200 |
| Kevin M. Brady CFO & Treasurer | Aug 20, 2026 | Sale | −3,400 | $625.24 | $2.13M | 12,830 |
| Kevin M. Brady CFO & Treasurer | Aug 20, 2026 | Option exercise | +3,400 | $138.87 | $472.16K | 16,230 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 20, 2026 | Sale | −27,174 | $618.79 | $16.81M | 561,195 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 19, 2026 | Sale | −15,609 | $606.47 | $9.47M | 588,369 |
| Brian T. Carley Director | Aug 19, 2026 | Sale | −5,000 | $608.63 | $3.04M | 27,825 |
| Fred B. Davenport Jr Director | Aug 19, 2026 | Option exercise | +3,858 | $84.36 | $325.46K | 9,259 |
| Fred B. Davenport Jr Director | Aug 19, 2026 | Option exercise | +1,822 | $164.68 | $300.05K | 11,081 |
| Fred B. Davenport Jr Director | Aug 19, 2026 | Sale | −7,283 | $606.15 | $4.41M | 3,798 |
| Fred B. Davenport Jr Director | Aug 19, 2026 | Option exercise | +1,903 | $133.87 | $254.75K | 5,401 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 13, 2026 | Sale | −458 | $600.39 | $274.98K | 603,978 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 12, 2026 | Sale | −11,366 | $601.53 | $6.84M | 604,436 |
| Cornelius P. McCarthy III Director | Aug 11, 2026 | Sale | −1,140 | $605.37 | $690.12K | 12,275 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 11, 2026 | Sale | −17,610 | $605.11 | $10.66M | 615,802 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 10, 2026 | Sale | −5,534 | $601.53 | $3.33M | 633,412 |
| Cornelius P. McCarthy III Director | Aug 7, 2026 | Sale | −795 | $585.07 | $465.13K | 13,415 |
| Cornelius P. McCarthy III Director | Aug 7, 2026 | Option exercise | +3,858 | $84.36 | $325.46K | 14,210 |
| Susan E. Burwig Exec. VP, Operations | Jul 28, 2026 | Sale | −7,500 | $600.00 | $4.50M | 62,984 |
| August J. Troendle President & CEO, Director, 10% owner | Jul 28, 2026 | Sale | −3,510 | $600.01 | $2.11M | 638,946 |
| August J. Troendle President & CEO, Director, 10% owner | Jul 27, 2026 | Sale | −3,728 | $600.85 | $2.24M | 642,456 |
| Brian T. Carley Director | Jun 30, 2026 | Option exercise | +36 | – | – | 32,825 |
| Cornelius P. McCarthy III Director | Jun 30, 2026 | Option exercise | +28 | – | – | 10,352 |
| Robert O. Kraft Director | Jun 30, 2026 | Option exercise | +33 | – | – | 955 |
| Stephen P. Ewald General Counsel & Corp. Secy. | May 28, 2026 | Sale | −16,349 | $450.00 | $7.36M | 20,343 |
| Stephen P. Ewald General Counsel & Corp. Secy. | May 28, 2026 | Option exercise | +16,349 | $138.87 | $2.27M | 36,692 |
| Kevin M. Brady CFO & Treasurer | Apr 24, 2026 | Option exercise | +7,000 | $138.87 | $972.09K | 12,830 |
| Stephen P. Ewald General Counsel & Corp. Secy. | Apr 24, 2026 | Option exercise | +3,500 | $138.87 | $486.05K | 20,343 |
| Cornelius P. McCarthy III Director | Mar 31, 2026 | Option exercise | +29 | – | – | 10,324 |
| Brian T. Carley Director | Mar 31, 2026 | Option exercise | +36 | – | – | 32,789 |
| Robert O. Kraft Director | Mar 31, 2026 | Option exercise | +33 | – | – | 922 |
| Susan E. Burwig Exec. VP, Operations | Mar 18, 2026 | Option exercise | +12,000 | $166.73 | $2.00M | 70,484 |
| Jesse J. Geiger President | Mar 17, 2026 | Option exercise | +31,707 | $138.87 | $4.40M | 46,707 |
| Jesse J. Geiger President | Mar 17, 2026 | Sale | −31,707 | $455.30 | $14.44M | 15,000 |
| Stephen P. Ewald General Counsel & Corp. Secy. | Feb 17, 2026 | Option exercise | +3,500 | $138.87 | $486.05K | 16,843 |
| Brian T. Carley Director | Feb 13, 2026 | Option exercise | +6,472 | $54.99 | $355.90K | 32,753 |
| Susan E. Burwig Exec. VP, Operations | Feb 13, 2026 | Option exercise | +10,984 | $107.93 | $1.19M | 58,484 |
| Cornelius P. McCarthy III Director | Dec 31, 2025 | Option exercise | +49 | – | – | 10,295 |
| Brian T. Carley Director | Dec 31, 2025 | Option exercise | +62 | – | – | 26,281 |
| Robert O. Kraft Director | Dec 31, 2025 | Option exercise | +56 | – | – | 889 |
| Susan E. Burwig Exec. VP, Operations | Dec 5, 2025 | Option exercise | +10,000 | $107.93 | $1.08M | 47,500 |
| August J. Troendle CEO, Director, 10% owner | Dec 3, 2025 | Sale | −668 | $590.69 | $394.58K | 646,184 |
| Susan E. Burwig Exec. VP, Operations | Dec 2, 2025 | Option exercise | +10,000 | $107.93 | $1.08M | 37,500 |
| August J. Troendle CEO, Director, 10% owner | Dec 2, 2025 | Sale | −5,698 | $590.47 | $3.36M | 646,852 |
| August J. Troendle CEO, Director, 10% owner | Dec 1, 2025 | Sale | −23,178 | $593.25 | $13.75M | 652,550 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Robert O. Kraft Director | Aug 26, 2026 | 3,858 | $2.38M | Aug 26, 2026 | Stock Option Exercise |
| Kevin M. Brady Officer | Aug 20, 2026 | 3,400 | $2.13M | Aug 20, 2026 | Stock Option Exercise |
| Brian T. Carley Director | Aug 19, 2026 | 5,000 | $3.04M | Aug 19, 2026 | Restricted Stock Vesting |
| Fred B. Davenport Jr Director | Aug 19, 2026 | 7,283 | $4.41M | Aug 19, 2026 | Stock Option Exercise |
| Cornelius P. McCarthy III Director | Aug 11, 2026 | 1,140 | $690.12K | Aug 11, 2026 | Stock Option Exercise |
| Cornelius P. McCarthy III Director | Aug 7, 2026 | 795 | $465.13K | Aug 7, 2026 | Stock Option Exercise |
| Jesse J. Geiger Former Officer | Jul 29, 2026 | 11,000 | $6.95M | Jul 23, 2026 | Stock Option Exercise |
| Jesse J. Geiger Former Officer | Jul 28, 2026 | 4,000 | $2.40M | Jul 28, 2026 | Stock Option Exercise |
| Susan E. Burwig Officer | Jul 28, 2026 | 7,500 | $4.50M | Jul 28, 2026 | Stock Option Exercise |
| J. Troendle August Chairman | Jul 27, 2026 | 307,959 | $184.78M | Jul 27, 2026 | NQ stock options |
| Jesse J. Geiger Former Officer | Jul 23, 2026 | 11,000 | $6.95M | Jul 23, 2026 | Stock Option Exercise |
| Stephen P. Ewald Officer | May 28, 2026 | 16,349 | $7.36M | May 28, 2026 | Option Granted - 02/15/2022 |
| Jesse J. Geiger Officer | Mar 17, 2026 | 31,707 | $14.51M | Mar 17, 2026 | Option Granted - 02/15/2022 |
| J. Troendle August Chairman | Nov 25, 2025 | 150,000 | $92.25M | Nov 25, 2025 | Grants |
| Susan E. Burwig Officer | Nov 24, 2025 | 20,000 | $12.18M | Nov 24, 2025 | Stock Option Exercise |